In addition, the GO and signal pathways related to N6AMT1 differed greatly in different tumors, but most were involved in cancer progression and immune-related directions, suggesting that N6AMT1 may affect cancer progression via its influence on the TME. The gene discussed is HEMK2; the disease is cancer.